Coutard Bruno, Canard Bruno
Laboratoire Architecture et Fonction des Macromolécules Biologiques, CNRS UMR-6098, Universités Aix-Marseille I et II, ESIL Case 925, 163 Avenue de Luminy, 13288 Marseille, France.
Antiviral Res. 2010 Aug;87(2):85-94. doi: 10.1016/j.antiviral.2010.02.326. Epub 2010 Mar 10.
VIZIER is an acronym for a research project entitled "Comparative Structural Genomics of Viral Enzymes Involved in Replication" funded by the European Commission between November 1st, 2004 and April 30th, 2009. It involved 25 partners from 12 countries. In this paper, we describe the organization of the project and the culture created by its multidisciplinary essence. We discuss the main thematic sections of the project and the strategy adopted to optimize the integration of various scientific fields into a common objective: to obtain crystal structures of the widest variety of RNA virus replication enzymes documented and validated as potential drug targets. We discuss the thematic sections and their overall organization, their successes and bottlenecks around the protein production pipeline, the "low hanging fruit" strategy, and measures directed to problem solving. We discuss possible future options for such large-scale projects in the area of antiviral drug design. In a series of accompanying papers in Antiviral Research, the project and its achievements are presented for each virus family.
VIZIER是一个研究项目的首字母缩写,该项目名为“参与复制的病毒酶的比较结构基因组学”,由欧盟委员会于2004年11月1日至2009年4月30日资助。它有来自12个国家的25个合作伙伴。在本文中,我们描述了该项目的组织架构及其多学科本质所营造的氛围。我们讨论了该项目的主要主题部分以及为优化将各个科学领域整合为一个共同目标所采用的策略:获得记录在案并经验证为潜在药物靶点的种类最为丰富的RNA病毒复制酶的晶体结构。我们讨论了主题部分及其总体架构、蛋白质生产流程中的成功与瓶颈、“低垂果实”策略以及针对解决问题所采取的措施。我们还讨论了在抗病毒药物设计领域此类大规模项目未来可能的选择。在《抗病毒研究》的一系列配套论文中,针对每个病毒家族介绍了该项目及其成果。